Pfizer looking attractive
Updated
Pfizer is experiencing the most aggressive sell-off in its history and technicals are aligning for a possible reversal. The stock has given back all of its COVID-19-induced gains and probably giving us a first entry opportunity.
Trade active
Pfizer stocks plunged after they gave a gloomy expectation for 2024. The news has already been priced in. Reloading on Pfizer today. It is in our desired price.Note
We closed our first Pfizer position at a slight entry and our second position which we entered at $26.26 is still running.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.